ATS 2019 Virtual Final Program

CLINICAL PEDIATRIC CLINICAL CORE CURRICULUM CME Credits Available: 1 MOC Points Available: 1 PCC2 PEDIATRIC CLINICAL CORE CURRICULUM 6:45 a.m. - 7:45 a.m. OMNI DALLAS DOWNTOWN Dallas Ballroom A-C (Level 3) Target Audience Pediatric pulmonary and critical care physicians who work in a clinical setting and are currently engaged in maintenance of certification Objectives At the conclusion of this session, the participant will be able to: • remain current with medical knowledge relevant to their practice in pediatric pulmonology; • evaluate their understanding of key skills and content areas in pediatric pulmonology as well as receive feedback on their comprehension of a result of a pre-test/post-test comparison; • support clinicians who are engaged in maintenance of certification activities by providing updates on subjects included in recertification requirements. The Pediatric Core Curriculum symposia promote lifelong learning and the enhancement of the clinical judgment and skills essential for practicing pediatrician. The symposia will address topics that have been identified by an ATS pediatric working group, which is comprised of members of the ATS Education Committee and the International Conference Committee, who have identified important areas within pediatric medicine (including severe asthma, ILD, BPD, pulmonary hypertension and pulmonary manifestations of pulmonary disease). Attendees will increase their medical knowledge as a result of attending this symposium, and this will be measured by a comparison of pre-test vs. post-test results on the corresponding maintenance of certification module. The ATS Pediatric Core Curriculum will focus on a 3-year content cycle of key medical content in the area of pediatric medicine. Chairing: P.E. Moore, MD, ATSF, Nashville, TN 6:45 Approach to Respiratory Viral Illness in Children T.C. Lewis, MD, MPH, Ann Arbor, MI 7:15 Management of Complicated Pneumonia and Empyema in Children C.R. Esther, MD, PhD, Chapel Hill, NC SUNRISE SEMINARS CME Credits Available: 1 R Registration Fee: $50.00 (includes continental breakfast.) Attendance is limited. Pre-registration is required. 6:45 a.m. - 7:45 a.m OMNI DALLAS DOWNTOWN SS101 SEVERE ASTHMA: BREAKING DOWN THE BASICS OF ADVANCED ASTHMA THERAPIES A.J. Oberle, MD, Durham, NC Greenville Avenue (Level 2) SS102 TARGETED THERAPEUTICS IN CYSTIC FIBROSIS G. Hong, MD, MHS, Philadelphia, PA Deep Ellum B (Level 2) SS103 STATE OF THE ART AND FUTURE “OMIC” APPROACHES TO DETECT LUNG TRANSPLANT REJECTION S. Agbor, MD, PhD, Bethesda, MD Deep Ellum A (Level 2) SS104 DIFFUSE CYSTIC LUNG DISEASE: EVALUATION AND MANAGEMENT L.A. Ho, MD, Seattle, WA Arts District 1 (Level 2) SS105 ILD DIAGNOSIS: SURGICAL LUNG BIOPSY, CRYOBIOPSY, AND EMERGING CUTTING-EDGE OPTICAL IMAGING TECHNIQUES R.S. Knipe, MD, Boston, MA C. Keyes, MD, MPH, Boston, MA L.P. Hariri, MD, PhD, Boston, MA Arts District 2 (Level 2) SS106 DIAGNOSIS AND MANAGEMENT OF MASSIVE HEMOPTYSIS G.Z. Cheng, MD, PhD, Durham, NC J. Cardenas-Garcia, MD, Ann Arbor, MI Arts District 3 (Level 2) SS107 THE CHANGING LANDSCAPE OF ONCOLOGIC CRITICAL CARE L. Munshi, MD, MSc, Toronto, Canada C. McEvoy, MD, St Louis, MO R.S. Stephens, MD, Baltimore, MD C. Gutierrez, MD, Houston, TX Arts District 4 (Level 2) SS108 2020 VISION: UPDATE ON THE INTERNATIONAL CLASSIFICATION OF PNEUMOCONIOSIS AND DIGITAL CHEST IMAGING R. Zulfikar, MBBS, MD, Morgantown, WV E.L. Petsonk, MD, Morgantown, WV Arts District 5 (Level 2) SS109 BEST LAID PLANS: IMPROVING CLINICAL TRIAL QUALITY THROUGH INTERVENTION FIDELITY MONITORING J. Tate, PhD, RN, Columbus, OH Arts District 6 (Level 2) SS110 THE BUGS THAT SHAPE US: UNDERSTANDING EVIDENCE ON THE EARLY-LIFE RESPIRATORY MICROBIOME C. Rosas-Salazar, MD, MPH, Nashville, TN Arts District 7 (Level 2) ATS 2019 • Dallas, TX MONDAY • MAY 20 121 MONDAY MORNING Monday Morning, May 20